Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer

S. Nishimura, H. Tsuda, Hiroyuki Nomura, Fumio Kataoka, Tatsuyuki Chiyoda, H. Tanaka, Kyoko Tanaka, N. Susumu, Daisuke Aoki

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

For both cervical cancer (UCC) and endometrial cancer (EMC) there are no effective prognostic markers. In this study, we evaluated HIG2 protein expression in 332 uterine cancers (186 UCCs and 146 EMCs) and examined the relationship between HIG2 protein expression and clinical factors, including prognosis. Totally, HIG2 expression was detected in 58% of UCC and 66% of EMC. However, there was no significant relationship between HIG2 expression and age, clinical stage and histology in either UCC or EMC. In addition, HIG2 protein expression was not related to prognosis of UCC or EMC. The positivity rate of HIG2 protein was 56% and 61% in early-stage UCC and EMC, respectively and 67% in non-squamous cell carcinoma of UCC. The positivity rate of HIG2 protein was high even in early-stage UCC and EMC.

Original languageEnglish
Pages (from-to)146-149
Number of pages4
JournalEuropean Journal of Gynaecological Oncology
Volume32
Issue number2
Publication statusPublished - 2011

Fingerprint

Uterine Neoplasms
Endometrial Neoplasms
Proteins
Uterine Cervical Neoplasms
Hypoxia
Histology
Carcinoma

Keywords

  • Adenocarcinoma
  • Cervical cancer
  • Endometrial cancer
  • HIG2

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer. / Nishimura, S.; Tsuda, H.; Nomura, Hiroyuki; Kataoka, Fumio; Chiyoda, Tatsuyuki; Tanaka, H.; Tanaka, Kyoko; Susumu, N.; Aoki, Daisuke.

In: European Journal of Gynaecological Oncology, Vol. 32, No. 2, 2011, p. 146-149.

Research output: Contribution to journalArticle

Nishimura, S, Tsuda, H, Nomura, H, Kataoka, F, Chiyoda, T, Tanaka, H, Tanaka, K, Susumu, N & Aoki, D 2011, 'Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer', European Journal of Gynaecological Oncology, vol. 32, no. 2, pp. 146-149.
Nishimura, S. ; Tsuda, H. ; Nomura, Hiroyuki ; Kataoka, Fumio ; Chiyoda, Tatsuyuki ; Tanaka, H. ; Tanaka, Kyoko ; Susumu, N. ; Aoki, Daisuke. / Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer. In: European Journal of Gynaecological Oncology. 2011 ; Vol. 32, No. 2. pp. 146-149.
@article{db7aeebdc75f4ac8b5a9abab3fa96675,
title = "Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer",
abstract = "For both cervical cancer (UCC) and endometrial cancer (EMC) there are no effective prognostic markers. In this study, we evaluated HIG2 protein expression in 332 uterine cancers (186 UCCs and 146 EMCs) and examined the relationship between HIG2 protein expression and clinical factors, including prognosis. Totally, HIG2 expression was detected in 58{\%} of UCC and 66{\%} of EMC. However, there was no significant relationship between HIG2 expression and age, clinical stage and histology in either UCC or EMC. In addition, HIG2 protein expression was not related to prognosis of UCC or EMC. The positivity rate of HIG2 protein was 56{\%} and 61{\%} in early-stage UCC and EMC, respectively and 67{\%} in non-squamous cell carcinoma of UCC. The positivity rate of HIG2 protein was high even in early-stage UCC and EMC.",
keywords = "Adenocarcinoma, Cervical cancer, Endometrial cancer, HIG2",
author = "S. Nishimura and H. Tsuda and Hiroyuki Nomura and Fumio Kataoka and Tatsuyuki Chiyoda and H. Tanaka and Kyoko Tanaka and N. Susumu and Daisuke Aoki",
year = "2011",
language = "English",
volume = "32",
pages = "146--149",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer

AU - Nishimura, S.

AU - Tsuda, H.

AU - Nomura, Hiroyuki

AU - Kataoka, Fumio

AU - Chiyoda, Tatsuyuki

AU - Tanaka, H.

AU - Tanaka, Kyoko

AU - Susumu, N.

AU - Aoki, Daisuke

PY - 2011

Y1 - 2011

N2 - For both cervical cancer (UCC) and endometrial cancer (EMC) there are no effective prognostic markers. In this study, we evaluated HIG2 protein expression in 332 uterine cancers (186 UCCs and 146 EMCs) and examined the relationship between HIG2 protein expression and clinical factors, including prognosis. Totally, HIG2 expression was detected in 58% of UCC and 66% of EMC. However, there was no significant relationship between HIG2 expression and age, clinical stage and histology in either UCC or EMC. In addition, HIG2 protein expression was not related to prognosis of UCC or EMC. The positivity rate of HIG2 protein was 56% and 61% in early-stage UCC and EMC, respectively and 67% in non-squamous cell carcinoma of UCC. The positivity rate of HIG2 protein was high even in early-stage UCC and EMC.

AB - For both cervical cancer (UCC) and endometrial cancer (EMC) there are no effective prognostic markers. In this study, we evaluated HIG2 protein expression in 332 uterine cancers (186 UCCs and 146 EMCs) and examined the relationship between HIG2 protein expression and clinical factors, including prognosis. Totally, HIG2 expression was detected in 58% of UCC and 66% of EMC. However, there was no significant relationship between HIG2 expression and age, clinical stage and histology in either UCC or EMC. In addition, HIG2 protein expression was not related to prognosis of UCC or EMC. The positivity rate of HIG2 protein was 56% and 61% in early-stage UCC and EMC, respectively and 67% in non-squamous cell carcinoma of UCC. The positivity rate of HIG2 protein was high even in early-stage UCC and EMC.

KW - Adenocarcinoma

KW - Cervical cancer

KW - Endometrial cancer

KW - HIG2

UR - http://www.scopus.com/inward/record.url?scp=79955684520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955684520&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 146

EP - 149

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 2

ER -